{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:27:23Z","timestamp":1794871643342,"version":"4.9.1"},"reference-count":53,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,13]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Acquired expression of CblQ367P induces sustained proliferation of myelomonocytes, multilineage dysplasia, and splenomegaly resembling CMML. Combined inhibition of PI3K and JAK2 efficiently suppressed the growth of CblQ367P-induced CMML cells.<\/jats:p>","DOI":"10.1182\/blood-2016-06-724658","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T02:00:54Z","timestamp":1487296854000},"page":"2148-2160","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":30,"title":["Acquired expression of CblQ367P in mice induces dysplastic myelopoiesis mimicking chronic myelomonocytic leukemia"],"prefix":"10.1182","volume":"129","author":[{"given":"Yuichiro","family":"Nakata","sequence":"first","affiliation":[{"name":"Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Kindai University, Osaka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Nagamachi","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimasa","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichiro","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Sera","sequence":"additional","affiliation":[{"name":"Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiyo","family":"Takubo","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Kanai","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokyo Women\u2019s Medical University, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sanada","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Medicine, Kyoto University, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Medicine, Kyoto University, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohichiro","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ebihara","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Wolff","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zen-ichiro","family":"Honda","sequence":"additional","affiliation":[{"name":"Health Service Center, Ochanomizu University, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Suda","sequence":"additional","affiliation":[{"name":"Cancer Science Institute of Singapore, Center for Translational Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Inaba","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"12","key":"2019111904415100900_B1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3321","article-title":"The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes","volume":"12","author":"Raza","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"2019111904415100900_B2","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2014-04-522136","article-title":"Recent developments in myelodysplastic syndromes","volume":"124","author":"Bejar","year":"2014","journal-title":"Blood"},{"key":"2019111904415100900_B3","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th ed"},{"issue":"7","key":"2019111904415100900_B4","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/leu.2013.100","article-title":"An evolutionary perspective on chronic myelomonocytic leukemia","volume":"27","author":"Itzykson","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"2019111904415100900_B5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/bjh.12756","article-title":"Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review","volume":"165","author":"Patnaik","year":"2014","journal-title":"Br J Haematol"},{"key":"2019111904415100900_B6","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1038\/bcj.2016.5","article-title":"Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia","volume":"6","author":"Patnaik","year":"2016","journal-title":"Blood Cancer J"},{"issue":"7257","key":"2019111904415100900_B7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature08240","article-title":"Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms","volume":"460","author":"Sanada","year":"2009","journal-title":"Nature"},{"key":"2019111904415100900_B8","article-title":"Oncogenic signaling by leukemia-associated mutant Cbl proteins","volume-title":"Biochem Anal Biochem","author":"Nadeau","year":"2012"},{"issue":"13","key":"2019111904415100900_B9","doi-asserted-by":"crossref","first-page":"10689","DOI":"10.18632\/oncotarget.3986","article-title":"Mutations of c-Cbl in myeloid malignancies","volume":"6","author":"Katzav","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"2019111904415100900_B10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbamcr.2012.10.010","article-title":"Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases","volume":"1833","author":"Mohapatra","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"2019111904415100900_B11","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1128\/MCB.18.8.4872","article-title":"Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice","volume":"18","author":"Murphy","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"26","key":"2019111904415100900_B12","doi-asserted-by":"crossref","first-page":"15547","DOI":"10.1073\/pnas.95.26.15547","article-title":"Altered thymic positive selection and intracellular signals in Cbl-deficient mice","volume":"95","author":"Naramura","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019111904415100900_B13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccr.2010.09.008","article-title":"Myeloid leukemia development in c-Cbl RING finger mutant mice is dependent on FLT3 signaling","volume":"18","author":"Rathinam","year":"2010","journal-title":"Cancer Cell"},{"issue":"5229","key":"2019111904415100900_B14","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.7660125","article-title":"Inducible gene targeting in mice","volume":"269","author":"K\u00fchn","year":"1995","journal-title":"Science"},{"issue":"16","key":"2019111904415100900_B15","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111904415100900_B16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/hon.745","article-title":"Chronic myelomonocytic leukemia: lost in classification?","volume":"23","author":"Bowen","year":"2005","journal-title":"Hematol Oncol"},{"issue":"6","key":"2019111904415100900_B17","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/leu.2010.69","article-title":"Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1","volume":"24","author":"Tefferi","year":"2010","journal-title":"Leukemia"},{"issue":"12","key":"2019111904415100900_B18","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1158\/0008-5472.CAN-10-0610","article-title":"Cbl and human myeloid neoplasms: the Cbl oncogene comes of age","volume":"70","author":"Kales","year":"2010","journal-title":"Cancer Res"},{"issue":"3","key":"2019111904415100900_B19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.18632\/oncotarget.233","article-title":"Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders","volume":"2","author":"Naramura","year":"2011","journal-title":"Oncotarget"},{"issue":"12","key":"2019111904415100900_B20","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2012-06-440347","article-title":"Clonal architecture of chronic myelomonocytic leukemias","volume":"121","author":"Itzykson","year":"2013","journal-title":"Blood"},{"issue":"7478","key":"2019111904415100900_B21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nature12830","article-title":"Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness","volume":"504","author":"Li","year":"2013","journal-title":"Nature"},{"issue":"8","key":"2019111904415100900_B22","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1128\/JVI.77.8.4965-4971.2003","article-title":"A Moloney murine leukemia virus-based retrovirus with 4070A long terminal repeat sequences induces a high incidence of myeloid as well as lymphoid neoplasms","volume":"77","author":"Wolff","year":"2003","journal-title":"J Virol"},{"issue":"10","key":"2019111904415100900_B23","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/hmg\/8.10.1955","article-title":"Mouse ENU mutagenesis","volume":"8","author":"Justice","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"13","key":"2019111904415100900_B24","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/onc.2009.475","article-title":"Identification of Zfp521\/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia","volume":"29","author":"Yamasaki","year":"2010","journal-title":"Oncogene"},{"issue":"3","key":"2019111904415100900_B25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ccr.2013.08.011","article-title":"Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7","volume":"24","author":"Nagamachi","year":"2013","journal-title":"Cancer Cell"},{"issue":"22","key":"2019111904415100900_B26","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1182\/blood-2014-03-562694","article-title":"Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2","volume":"125","author":"Ueda","year":"2015","journal-title":"Blood"},{"issue":"37","key":"2019111904415100900_B27","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1073\/pnas.1600070113","article-title":"Propagation of trimethylated H3K27 regulated by polycomb protein EED is required for embryogenesis, hematopoietic maintenance, and tumor suppression","volume":"113","author":"Ueda","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111904415100900_B28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2005.09.020","article-title":"EVI1 and hematopoietic disorders: history and perspectives","volume":"368","author":"Nucifora","year":"2006","journal-title":"Gene"},{"issue":"1","key":"2019111904415100900_B29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biocel.2007.01.026","article-title":"PU.1: a crucial and versatile player in hematopoiesis and leukemia","volume":"40","author":"Kastner","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"2019111904415100900_B30","first-page":"114","article-title":"The RASSF proteins in cancer; from epigenetic silencing to functional characterization","volume":"1796","author":"Richter","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"2019111904415100900_B31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/978-1-4614-2098-9_11","article-title":"Mobilization and homing of hematopoietic stem cells","volume":"741","author":"Su\u00e1rez-\u00c1lvarez","year":"2012","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"2019111904415100900_B32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1586\/ehm.11.30","article-title":"The bone marrow microenvironment and leukemia: biology and therapeutic targeting","volume":"4","author":"Sison","year":"2011","journal-title":"Expert Rev Hematol"},{"issue":"14","key":"2019111904415100900_B33","doi-asserted-by":"crossref","first-page":"R496","DOI":"10.1016\/S0960-9822(02)00968-5","article-title":"Gem GTPase: between a ROCK and a hard place","volume":"12","author":"Olson","year":"2002","journal-title":"Curr Biol"},{"issue":"2","key":"2019111904415100900_B34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cellsig.2007.10.028","article-title":"The RGK family of GTP-binding proteins: regulators of voltage-dependent calcium channels and cytoskeleton remodeling","volume":"20","author":"Correll","year":"2008","journal-title":"Cell Signal"},{"issue":"2","key":"2019111904415100900_B35","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jmb.2011.08.017","article-title":"RGK family G-domain:GTP analog complex structures and nucleotide-binding properties","volume":"413","author":"Sasson","year":"2011","journal-title":"J Mol Biol"},{"issue":"10","key":"2019111904415100900_B36","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.1035850100","article-title":"Identification of genes involved in cell invasion by using a library of randomized hybrid ribozymes","volume":"100","author":"Suyama","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2019111904415100900_B37","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1096\/fj.12-209460","article-title":"The GTPase Gem and its partner Kif9 are required for chromosome alignment, spindle length control, and mitotic progression","volume":"26","author":"Andrieu","year":"2012","journal-title":"FASEB J"},{"issue":"11","key":"2019111904415100900_B38","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1093\/carcin\/bgu185","article-title":"Gem GTPase acts upstream Gmip\/RhoA to regulate cortical actin remodeling and spindle positioning during early mitosis","volume":"35","author":"Andrieu","year":"2014","journal-title":"Carcinogenesis"},{"key":"2019111904415100900_B39","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1186\/1471-2407-14-638","article-title":"High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer","volume":"14","author":"Laurberg","year":"2014","journal-title":"BMC Cancer"},{"issue":"9","key":"2019111904415100900_B40","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.18632\/oncotarget.1883","article-title":"Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma","volume":"5","author":"Cazes","year":"2014","journal-title":"Oncotarget"},{"issue":"26","key":"2019111904415100900_B41","doi-asserted-by":"crossref","first-page":"15149","DOI":"10.1073\/pnas.211566398","article-title":"Multiclass cancer diagnosis using tumor gene expression signatures","volume":"98","author":"Ramaswamy","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019111904415100900_B42","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019111904415100900_B43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2141.2010.08381.x","article-title":"ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia","volume":"151","author":"Gelsi-Boyer","year":"2010","journal-title":"Br J Haematol"},{"issue":"12","key":"2019111904415100900_B44","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood-2013-10-533844","article-title":"Tracing the development of acute myeloid leukemia in CBL syndrome","volume":"123","author":"Becker","year":"2014","journal-title":"Blood"},{"issue":"11","key":"2019111904415100900_B45","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/leu.2014.125","article-title":"ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients","volume":"28","author":"Patnaik","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"2019111904415100900_B46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/ejh.12549","article-title":"Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation","volume":"96","author":"Peng","year":"2016","journal-title":"Eur J Haematol"},{"key":"2019111904415100900_B47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.genom.3.032802.115046","article-title":"Genetics of myeloid leukemias","volume":"3","author":"Kelly","year":"2002","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2019111904415100900_B48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1756-8722-4-36","article-title":"Current findings for recurring mutations in acute myeloid leukemia","volume":"4","author":"Takahashi","year":"2011","journal-title":"J Hematol Oncol"},{"issue":"4","key":"2019111904415100900_B49","doi-asserted-by":"crossref","first-page":"e94717","DOI":"10.1371\/journal.pone.0094717","article-title":"Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice","volume":"9","author":"Duyvestyn","year":"2014","journal-title":"PLoS One"},{"issue":"76","key":"2019111904415100900_B50","doi-asserted-by":"crossref","first-page":"76ra27","DOI":"10.1126\/scitranslmed.3001069","article-title":"A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice","volume":"3","author":"Lyubynska","year":"2011","journal-title":"Sci Transl Med"},{"issue":"1","key":"2019111904415100900_B51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1172\/JCI63193","article-title":"Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice","volume":"123","author":"Chang","year":"2013","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111904415100900_B52","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1172\/JCI74182","article-title":"Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm","volume":"124","author":"Kong","year":"2014","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111904415100900_B53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.20042541","article-title":"Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis","volume":"202","author":"Kato","year":"2005","journal-title":"J Exp Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/15\/2148\/1400626\/blood724658.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/15\/2148\/1400626\/blood724658.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T09:42:20Z","timestamp":1574156540000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/15\/2148\/36445\/Acquired-expression-of-CblQ367P-in-mice-induces"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":53,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,4,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-06-724658","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]}}}